Over-the-Counter (OTC) Analgesics Market Analysis North America,Europe,Asia,Rest of World (ROW) - US,Germany,UK,China,Japan - Size and Forecast 2023-2027

Published: Oct 2023

Pages: 165

SKU: IRTNTR43442

Snapshot

Over-the-Counter (OTC) Analgesics Market Forecast 2023-2027

The Over-the-Counter (OTC) Analgesics Market size is estimated to grow by USD 6.52 billion at a CAGR of 4.74% between 2022 and 2027.

The shifting global demographic landscape, marked by a growing aging population, is spurring demand for Over-the-Counter (OTC) analgesics. In 2022, approximately 771 million individuals worldwide were aged 65 or older, comprising about 10% of the global population. As people live longer, they encounter age-related health issues, increasing the likelihood of chronic pain. This drives the need for accessible pain relief solutions, with OTC analgesics emerging as a crucial response. Elderly individuals often contend with conditions like arthritis and musculoskeletal disorders, necessitating daily pain management for a reasonable quality of life. OTC analgesics like acetaminophen and NSAIDs provide practical relief without prescriptions, aligning with seniors' desire for self-care and independence. Their widespread availability in pharmacies, supermarkets, and online platforms ensures convenient access, particularly beneficial for fixed-income seniors. Consequently, the aging population's growth is expected to propel the global OTC analgesics market forward.

What will be the Size of the Market During the Forecast Period?

To learn more about this report, Request Free Sample

Market Segmentation by Type, Distribution Channel, and Geography Analysis

Type Analysis

The internal segment is estimated to witness significant growth during the forecast period. The main purpose of internal analgesics is for internal use and are either taken by mouth in the form of pills and liquids or inserted into the rectum in suppository form. This segment is available in a wide variety of formulations, such as tablets, capsules, liquid solutions, and syrup. Some of the main drugs included in the internal segment are acetaminophen, aspirin, and nonsteroidal anti-inflammatory drugs (NSAIDs).

Get a glance at the market contribution of various segments View a PDF Sample

The internal segment was the largest segment and was valued at USD 17.08 billion in 2017. Some of the prominent internal OTC analgesic brands include Aleve, Advil, Crocin, MOTRIN, Aspirin, Excedrin, and TYLENO. In addition. some of the key factors that are significantly contributing to the growth of this segment include the increasing prevalence of pain-related conditions, rising awareness of self-medication, strong advertisements by key vendors to promote their OTC analgesics, and rising healthcare expenditure. There is an increase in demand for OTC analgesics across the world due to the growing awareness of self-medication. Hence, such factors are fuelling the growth of this segment which in turn will drive the market growth during the forecast period.

Distribution Channel Analysis

The offline segment for OTC analgesics comprises traditional and physical retail outlets where consumers can directly purchase these non-prescription pain relief products. This segment is vital in offering immediate access and personalized assistance to consumers seeking relief from different types of pain. Some of the trusted sources of OTC analgesics include pharmacies and drugstores. Some of the retail giants that offer a wide array of pain relief options include Walgreens, CVS Health in the United States, and Boots in the United Kingdom. Hence, factors such as widespread availability and accessibility coupled with the personalized touch it offers to customers are expected to fuel the growth of this segment which in turn will drive the market growth during the forecast period.

Regional Analysis

For more insights about the market share of various regions View PDF Sample now!

North America is estimated to contribute 42% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that will shape the market during the forecast period. Some of the main factors that are significantly contributing to the growth of the OTC analgesics market in North America include increasing healthcare expenditure, the high prevalence of pain-related conditions and arthritis, the strong presence of vendors in the region, and favorable government policies.

Moreover, one of the main countries in North America which have significantly contributed to the market growth in the region is the US due to the increasing prevalence of pain-related conditions such as headaches, migraines, arthritis, muscle sprain, and joint pain. In addition, there is a strong presence of market players in the region which is also positively impacting the over-the-counter analgesics market growth. Hence, such factors are expected to drive market growth in North America during the forecast period.

Buy Now Full Report and Discover More

Key Over the Counter (OTC) Analgesics Market Players

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market. The market forecasting report also includes detailed analyses of the competitive landscape of the market and information about 20 market companies, including:

Bayer AG: The company offers over the counter analgesics used for chronic pain and migraine.

Qualitative and quantitative analysis of companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize companies as dominant, leading, strong, tentative, and weak.

Market Dynamics

There are multiple factors influencing market growth. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges.

Key Drivers

One of the key factors driving the market growth is the growing aging population globally. There has been a significant shift in the global demographic landscape due to the growing aging population which is significantly contributing to the market growth. There is an increase in age-related issues among people across the globe as people are living longer lives. As a result, there is a higher chance of experiencing chronic pain and discomfort.

Moreover, there is an increase in demand for accessible and effective pain relief solutions which is fuelling the demand for OTC analgesics. Some of the key conditions in elderly people include arthritis, musculoskeletal disorders, and various age-related ailments that result in chronic pain. As a result, there is an increase in the adoption of OTC analgesics, including acetaminophen and nonsteroidal anti-inflammatory drugs (NSAIDs), as they offer a practical and accessible means of addressing these persistent discomforts without the necessity of a prescription.

Significant Trends

A key factor shaping the market growth is the growing number of launches of OTC analgesics. There is a growing development of research and development for OTC analgesic drugs due to the increasing need for efficacious and better-tolerated medications. The market also offers huge growth opportunities for companies, due to the presence of a huge patient pool and the increasing demand for OTC drugs.

Moreover, there is an increasing focus by market players on developing new OTC analgesics with new formulations. As a result, they are introducing products with regulatory approvals, which can help them expand their product portfolio and maximize their sales. For example, in February 2020, GlaxoSmithKline received US FDA approval for Voltaren Arthritis Pain (diclofenac sodium topical gel, 1% (NSAID) as an OTC product for the temporary relief of arthritis pain in the hand, wrist, elbow, foot, and ankle, or knee in adults above 18 years of age. Hence, such factors are positively impacting the market trends.

Major Challenges

The growing number of product recalls is one of the key challenges hindering market growth. The pharmaceutical industry is prone to frequent product recalls due to safety and functionality issues. Pharmaceutical products need to be checked, adjusted, or fixed to ensure that they adhere to regulatory guidelines. In addition, market players must recall their products to prevent adverse effects on patients.

Moreover, some of the main factors that can lead to product recalls include errors in drug composition, warnings, labeling, and expiry date information. In addition, other factors such as manufacturing defects, technical errors, labeling errors, and API concentration faults can result in product recalls. Hence, such product recalls can hamper the industry's reputation and impact consumer confidence in the industry.

Buy Now Full Report and Discover More

Key Customer Landscape

The market growth analysis report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the market growth and forecasting report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Customer Landscape

Market Analyst Overview

The Over-the-Counter (OTC) Analgesics Market witnesses heightened demand amidst the current scenario, with fever, cough, cold, nasal congestion, and fatigue prevalent during the pandemic. Topical analgesics gain traction, particularly among the geriatric population battling various diseases. Cost-efficiency drives the market, supported by research from esteemed journals like the Annals of Medicine and Surgery and BioMed Central (BMC). Regional insights from the China Pain Health Index (CPHI) highlight significant demand in urban centers like Beijing, Shanghai, Zhejiang, Shandong, and Tianjin, particularly among the elderly population frequenting hospitals. Despite concerns regarding drug tolerance, dependence, addiction, and abuse, basic OTC analgesic products remain vital, serving diverse demographics including pregnant women. Studies from the National Center for Biotechnology Information (NCBI) and Frontiers in Human Neuroscience provide insights into organ dysfunction and chronic diseases management with cyclooxygenases (COX).

Segment Overview

The market research and growth report forecasts market growth by revenue at global, regional & country levels and provides an analysis of the latest trends and growth opportunities from 2017 to 2027.

Type Outlook (USD billion, 2017 - 2027)
- Internal
- External
Distribution Channel Outlook (USD billion, 2017 - 2027)
- Offline
- Online
Geography Outlook (USD billion, 2017 - 2027)
- North America
  - The U.S.
  - Canada
- Europe
  - The U.K.
  - Germany
  - France
  - Rest of Europe
- Asia
  - China
  - India
- Rest of the World
  - Australia
  - Argentina
  - Brazil

Over the Counter (OTC) Analgesics Market Scope
Market Report Coverage	Details
Page number	165
Base year	2022
Historic period	2017-2021
Forecast period	2023-2027
Growth momentum & CAGR	Accelerate at a CAGR of 4.74%
Market growth 2023-2027	USD 6.52 billion
Market structure	Fragmented
YoY growth 2022-2023(%)	4.51
Regional analysis	North America, Europe, Asia, and the Rest of the World (ROW)
Performing market contribution	North America at 42%
Key countries	US, Germany, UK, China, and Japan
Competitive landscape	Leading Vendors, Market Positioning of Vendors, Competitive Strategies, and Industry Risks
Key companies profiled	AstraZeneca Plc, Bayer AG, Boehringer Ingelheim International GmbH, Cardinal Health Inc., Cipla Ltd., CV Sciences Inc., Endo International Plc, GlaxoSmithKline Plc, Medterra CBD, Novartis AG, Perrigo Co. Plc, Pfizer Inc., Piramal Enterprises Ltd., Reckitt Benckiser Group Plc, Sanofi, Sun Pharmaceutical Industries Ltd., Takeda Pharmaceutical Co. Ltd., Teva Pharmaceutical Industries Ltd., Viatris Inc., Weefsel Pharma, and AKUMS
Market dynamics	Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, and Market condition analysis for the forecast period.
Customization purview	If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View Sample PDF at your Fingertips

What are the Key Data Covered in this Market Research Report?

CAGR of the market during the forecast period
Detailed information on factors that will drive the growth of the market between 2023 and 2027
Precise estimation of the market size and its contribution to the market in focus on the parent market
Detailed analysis of customer landscape covering Diver of price sensitivity, Adoption of the lifecycle, and key purchase criteria
Companies landscape comparing criticality of inputs and factors of differentiation
Exclusive Matrix on companies position and classification
Accurate predictions about upcoming trends and changes in consumer behavior
Growth of the market across North America, Europe, Asia, and the Rest of the World (ROW)
A thorough analysis of the market’s competitive landscape and detailed information about companies
Comprehensive analysis of factors that will challenge the growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. Get in touch

Table of Contents

1 Executive Summary

1.1 Market overview
- Exhibit 01: Executive Summary – Chart on Market Overview
- Exhibit 02: Executive Summary – Data Table on Market Overview
- Exhibit 03: Executive Summary – Chart on Global Market Characteristics
- Exhibit 04: Executive Summary – Chart on Market by Geography
- Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
- Exhibit 06: Executive Summary – Chart on Market Segmentation by Distribution Channel
- Exhibit 07: Executive Summary – Chart on Incremental Growth
- Exhibit 08: Executive Summary – Data Table on Incremental Growth
- Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
- Exhibit 10: Parent market
- Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
- Exhibit 12: Offerings of vendors included in the market definition

3.2 Market segment analysis
- Exhibit 13: Market segments

3.3 Market size 2022

3.4 Market outlook: Forecast for 2022-2027
- Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ billion)
- Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ billion)
- Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
- Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

4 Historic Market Size

4.1 Global over the counter analgesics market 2017 - 2021
- Exhibit 18: Historic Market Size – Data Table on global over the counter analgesics market 2017 - 2021 ($ billion)

4.2 Type Segment Analysis 2017 - 2021
- Exhibit 19: Historic Market Size – Type Segment 2017 - 2021 ($ billion)

4.3 Distribution Channel Segment Analysis 2017 - 2021
- Exhibit 20: Historic Market Size – Distribution Channel Segment 2017 - 2021 ($ billion)

4.4 Geography Segment Analysis 2017 - 2021
- Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ billion)

4.5 Country Segment Analysis 2017 - 2021
- Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ billion)

5 Five Forces Analysis

5.1 Five forces summary
- Exhibit 23: Five forces analysis - Comparison between 2022 and 2027

5.2 Bargaining power of buyers
- Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027

5.3 Bargaining power of suppliers
- Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027

5.4 Threat of new entrants
- Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027

5.5 Threat of substitutes
- Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027

5.6 Threat of rivalry
- Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027

5.7 Market condition
- Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

6 Market Segmentation by Type

6.1 Market segments
- Exhibit 30: Chart on Type - Market share 2022-2027 (%)
- Exhibit 31: Data Table on Type - Market share 2022-2027 (%)

6.2 Comparison by Type
- Exhibit 32: Chart on Comparison by Type
- Exhibit 33: Data Table on Comparison by Type

6.3 Internal - Market size and forecast 2022-2027
- Exhibit 34: Chart on Internal - Market size and forecast 2022-2027 ($ billion)
- Exhibit 35: Data Table on Internal - Market size and forecast 2022-2027 ($ billion)
- Exhibit 36: Chart on Internal - Year-over-year growth 2022-2027 (%)
- Exhibit 37: Data Table on Internal - Year-over-year growth 2022-2027 (%)

6.4 External - Market size and forecast 2022-2027
- Exhibit 38: Chart on External - Market size and forecast 2022-2027 ($ billion)
- Exhibit 39: Data Table on External - Market size and forecast 2022-2027 ($ billion)
- Exhibit 40: Chart on External - Year-over-year growth 2022-2027 (%)
- Exhibit 41: Data Table on External - Year-over-year growth 2022-2027 (%)

6.5 Market opportunity by Type
- Exhibit 42: Market opportunity by Type ($ billion)
- Exhibit 43: Data Table on Market opportunity by Type ($ billion)

7 Market Segmentation by Distribution Channel

7.1 Market segments
- Exhibit 44: Chart on Distribution Channel - Market share 2022-2027 (%)
- Exhibit 45: Data Table on Distribution Channel - Market share 2022-2027 (%)

7.2 Comparison by Distribution Channel
- Exhibit 46: Chart on Comparison by Distribution Channel
- Exhibit 47: Data Table on Comparison by Distribution Channel

7.3 Offline - Market size and forecast 2022-2027
- Exhibit 48: Chart on Offline - Market size and forecast 2022-2027 ($ billion)
- Exhibit 49: Data Table on Offline - Market size and forecast 2022-2027 ($ billion)
- Exhibit 50: Chart on Offline - Year-over-year growth 2022-2027 (%)
- Exhibit 51: Data Table on Offline - Year-over-year growth 2022-2027 (%)

7.4 Online - Market size and forecast 2022-2027
- Exhibit 52: Chart on Online - Market size and forecast 2022-2027 ($ billion)
- Exhibit 53: Data Table on Online - Market size and forecast 2022-2027 ($ billion)
- Exhibit 54: Chart on Online - Year-over-year growth 2022-2027 (%)
- Exhibit 55: Data Table on Online - Year-over-year growth 2022-2027 (%)

7.5 Market opportunity by Distribution Channel
- Exhibit 56: Market opportunity by Distribution Channel ($ billion)
- Exhibit 57: Data Table on Market opportunity by Distribution Channel ($ billion)

8 Customer Landscape

8.1 Customer landscape overview
- Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
- Exhibit 59: Chart on Market share by geography 2022-2027 (%)
- Exhibit 60: Data Table on Market share by geography 2022-2027 (%)

9.2 Geographic comparison
- Exhibit 61: Chart on Geographic comparison
- Exhibit 62: Data Table on Geographic comparison

9.3 North America - Market size and forecast 2022-2027
- Exhibit 63: Chart on North America - Market size and forecast 2022-2027 ($ billion)
- Exhibit 64: Data Table on North America - Market size and forecast 2022-2027 ($ billion)
- Exhibit 65: Chart on North America - Year-over-year growth 2022-2027 (%)
- Exhibit 66: Data Table on North America - Year-over-year growth 2022-2027 (%)

9.4 Europe - Market size and forecast 2022-2027
- Exhibit 67: Chart on Europe - Market size and forecast 2022-2027 ($ billion)
- Exhibit 68: Data Table on Europe - Market size and forecast 2022-2027 ($ billion)
- Exhibit 69: Chart on Europe - Year-over-year growth 2022-2027 (%)
- Exhibit 70: Data Table on Europe - Year-over-year growth 2022-2027 (%)

9.5 Asia - Market size and forecast 2022-2027
- Exhibit 71: Chart on Asia - Market size and forecast 2022-2027 ($ billion)
- Exhibit 72: Data Table on Asia - Market size and forecast 2022-2027 ($ billion)
- Exhibit 73: Chart on Asia - Year-over-year growth 2022-2027 (%)
- Exhibit 74: Data Table on Asia - Year-over-year growth 2022-2027 (%)

9.6 Rest of World (ROW) - Market size and forecast 2022-2027
- Exhibit 75: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
- Exhibit 76: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ billion)
- Exhibit 77: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
- Exhibit 78: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)

9.7 US - Market size and forecast 2022-2027
- Exhibit 79: Chart on US - Market size and forecast 2022-2027 ($ billion)
- Exhibit 80: Data Table on US - Market size and forecast 2022-2027 ($ billion)
- Exhibit 81: Chart on US - Year-over-year growth 2022-2027 (%)
- Exhibit 82: Data Table on US - Year-over-year growth 2022-2027 (%)

9.8 Germany - Market size and forecast 2022-2027
- Exhibit 83: Chart on Germany - Market size and forecast 2022-2027 ($ billion)
- Exhibit 84: Data Table on Germany - Market size and forecast 2022-2027 ($ billion)
- Exhibit 85: Chart on Germany - Year-over-year growth 2022-2027 (%)
- Exhibit 86: Data Table on Germany - Year-over-year growth 2022-2027 (%)

9.9 China - Market size and forecast 2022-2027
- Exhibit 87: Chart on China - Market size and forecast 2022-2027 ($ billion)
- Exhibit 88: Data Table on China - Market size and forecast 2022-2027 ($ billion)
- Exhibit 89: Chart on China - Year-over-year growth 2022-2027 (%)
- Exhibit 90: Data Table on China - Year-over-year growth 2022-2027 (%)

9.10 UK - Market size and forecast 2022-2027
- Exhibit 91: Chart on UK - Market size and forecast 2022-2027 ($ billion)
- Exhibit 92: Data Table on UK - Market size and forecast 2022-2027 ($ billion)
- Exhibit 93: Chart on UK - Year-over-year growth 2022-2027 (%)
- Exhibit 94: Data Table on UK - Year-over-year growth 2022-2027 (%)

9.11 Japan - Market size and forecast 2022-2027
- Exhibit 95: Chart on Japan - Market size and forecast 2022-2027 ($ billion)
- Exhibit 96: Data Table on Japan - Market size and forecast 2022-2027 ($ billion)
- Exhibit 97: Chart on Japan - Year-over-year growth 2022-2027 (%)
- Exhibit 98: Data Table on Japan - Year-over-year growth 2022-2027 (%)

9.12 Market opportunity by geography
- Exhibit 99: Market opportunity by geography ($ billion)
- Exhibit 100: Data Tables on Market opportunity by geography ($ billion)

10 Drivers, Challenges, and Trends

10.1 Market drivers

10.2 Market challenges

10.3 Impact of drivers and challenges
- Exhibit 101: Impact of drivers and challenges in 2022 and 2027

10.4 Market trends

11 Vendor Landscape

11.1 Overview

11.2 Vendor landscape
- Exhibit 102: Overview on Criticality of inputs and Factors of differentiation

11.3 Landscape disruption
- Exhibit 103: Overview on factors of disruption

11.4 Industry risks
- Exhibit 104: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
- Exhibit 105: Vendors covered

12.2 Market positioning of vendors
- Exhibit 106: Matrix on vendor position and classification

12.3 AstraZeneca Plc
- Exhibit 107: AstraZeneca Plc - Overview
- Exhibit 108: AstraZeneca Plc - Product / Service
- Exhibit 109: AstraZeneca Plc - Key news
- Exhibit 110: AstraZeneca Plc - Key offerings

12.4 Bayer AG
- Exhibit 111: Bayer AG - Overview
- Exhibit 112: Bayer AG - Business segments
- Exhibit 113: Bayer AG - Key news
- Exhibit 114: Bayer AG - Key offerings
- Exhibit 115: Bayer AG - Segment focus

12.5 Boehringer Ingelheim International GmbH
- Exhibit 116: Boehringer Ingelheim International GmbH - Overview
- Exhibit 117: Boehringer Ingelheim International GmbH - Business segments
- Exhibit 118: Boehringer Ingelheim International GmbH - Key news
- Exhibit 119: Boehringer Ingelheim International GmbH - Key offerings
- Exhibit 120: Boehringer Ingelheim International GmbH - Segment focus

12.6 Cipla Ltd.
- Exhibit 121: Cipla Ltd. - Overview
- Exhibit 122: Cipla Ltd. - Business segments
- Exhibit 123: Cipla Ltd. - Key news
- Exhibit 124: Cipla Ltd. - Key offerings
- Exhibit 125: Cipla Ltd. - Segment focus

12.7 Endo International Plc
- Exhibit 126: Endo International Plc - Overview
- Exhibit 127: Endo International Plc - Business segments
- Exhibit 128: Endo International Plc - Key news
- Exhibit 129: Endo International Plc - Key offerings
- Exhibit 130: Endo International Plc - Segment focus

12.8 GlaxoSmithKline Plc
- Exhibit 131: GlaxoSmithKline Plc - Overview
- Exhibit 132: GlaxoSmithKline Plc - Business segments
- Exhibit 133: GlaxoSmithKline Plc - Key news
- Exhibit 134: GlaxoSmithKline Plc - Key offerings
- Exhibit 135: GlaxoSmithKline Plc - Segment focus

12.9 Medterra CBD
- Exhibit 136: Medterra CBD - Overview
- Exhibit 137: Medterra CBD - Product / Service
- Exhibit 138: Medterra CBD - Key offerings

12.10 Novartis AG
- Exhibit 139: Novartis AG - Overview
- Exhibit 140: Novartis AG - Business segments
- Exhibit 141: Novartis AG - Key offerings
- Exhibit 142: Novartis AG - Segment focus

12.11 Perrigo Co. Plc
- Exhibit 143: Perrigo Co. Plc - Overview
- Exhibit 144: Perrigo Co. Plc - Business segments
- Exhibit 145: Perrigo Co. Plc - Key news
- Exhibit 146: Perrigo Co. Plc - Key offerings
- Exhibit 147: Perrigo Co. Plc - Segment focus

12.12 Pfizer Inc.
- Exhibit 148: Pfizer Inc. - Overview
- Exhibit 149: Pfizer Inc. - Product / Service
- Exhibit 150: Pfizer Inc. - Key news
- Exhibit 151: Pfizer Inc. - Key offerings

12.13 Reckitt Benckiser Group Plc
- Exhibit 152: Reckitt Benckiser Group Plc - Overview
- Exhibit 153: Reckitt Benckiser Group Plc - Business segments
- Exhibit 154: Reckitt Benckiser Group Plc - Key offerings
- Exhibit 155: Reckitt Benckiser Group Plc - Segment focus

12.14 Sanofi
- Exhibit 156: Sanofi - Overview
- Exhibit 157: Sanofi - Business segments
- Exhibit 158: Sanofi - Key news
- Exhibit 159: Sanofi - Key offerings
- Exhibit 160: Sanofi - Segment focus

12.15 Sun Pharmaceutical Industries Ltd.
- Exhibit 161: Sun Pharmaceutical Industries Ltd. - Overview
- Exhibit 162: Sun Pharmaceutical Industries Ltd. - Product / Service
- Exhibit 163: Sun Pharmaceutical Industries Ltd. - Key offerings

12.16 Takeda Pharmaceutical Co. Ltd.
- Exhibit 164: Takeda Pharmaceutical Co. Ltd. - Overview
- Exhibit 165: Takeda Pharmaceutical Co. Ltd. - Product / Service
- Exhibit 166: Takeda Pharmaceutical Co. Ltd. - Key news
- Exhibit 167: Takeda Pharmaceutical Co. Ltd. - Key offerings

12.17 Viatris Inc.
- Exhibit 168: Viatris Inc. - Overview
- Exhibit 169: Viatris Inc. - Business segments
- Exhibit 170: Viatris Inc. - Key news
- Exhibit 171: Viatris Inc. - Key offerings
- Exhibit 172: Viatris Inc. - Segment focus

13 Appendix

13.1 Scope of the report

13.2 Inclusions and exclusions checklist
- Exhibit 173: Inclusions checklist
- Exhibit 174: Exclusions checklist

13.3 Currency conversion rates for US$
- Exhibit 175: Currency conversion rates for US$

13.4 Research methodology
- Exhibit 176: Research methodology
- Exhibit 177: Validation techniques employed for market sizing
- Exhibit 178: Information sources

13.5 List of abbreviations
- Exhibit 179: List of abbreviations

Methodology

Research Framework

Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

INFORMATION SOURCES

Primary sources

Manufacturers and suppliers
Channel partners
Industry experts
Strategic decision makers

Secondary sources

Industry journals and periodicals
Government data
Financial reports of key industry players
Historical data
Press releases

DATA ANALYSIS

Data Synthesis

Collation of data
Estimation of key figures
Analysis of derived insights

Data Validation

Triangulation with data models
Reference against proprietary databases
Corroboration with industry experts

REPORT WRITING

Qualitative

Market drivers
Market challenges
Market trends
Five forces analysis

Quantitative

Market size and forecast
Market segmentation
Geographical insights
Competitive landscape

Purchase Report

PURCHASE FULL REPORT OF

over the counter (otc) analgesics market market

Buy Report - Single User License 2500 USD

QUICK BUY

Key Questions Answered

What are the key global market and the regional market share?
What are the revenue-generating key market segments?
What are the key factors driving and challenging this market’s growth?
Who are the key market vendors and their growth strategies?
What are the latest trends influencing the growth of this market?
What are the variables influencing the market growth in the primary regions?
What are the factors influencing the growth of the parent market?

Why should you prefer Technavio's market insights report?

Off-the-shelf research reports
Reports can be tailored to meet the customer's needs
Trusted by more than 100 fortune 500 organizations
Information about the market's key drivers, trends, and challenges
Parent market analysis
Every week, 50,000 people visit our subscription platform
Detailed vendors report with competitive landscape
Covid-19 impact and recovery analysis
Data on revenue-generating market segments
Details on the market shares of various regions
Five-force market analysis